12 Sources of evidence considered by the Committee

12 Sources of evidence considered by the Committee

The diagnostics assessment report for this assessment was prepared by BMJ Technology Assessment Group (BMJ‑TAG).

  • Edwards SJ, Mavranezouli I, Osei‑Assibey G et al. VivaScope 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation. A Diagnostic Assessment Report. April 2015.

Registered stakeholders

The following organisations accepted the invitation to participate in this assessment as registered stakeholders. They were invited to attend the scoping workshop and to comment on the diagnostics assessment report and the diagnostics consultation document.

Manufacturer(s) of technologies included in the final scope:

  • MAVIG GmbH

Other commercial organisations:

  • Michelson Diagnostics

  • XY Consulting

Professional groups and patient/carer groups:

  • Royal College of Pathologists

  • Royal College of Physicians

  • British Association of Dermatologists

Research groups:

  • Cancer Research UK

  • Skin Cancer Research Fund

Associated guideline groups:

  • None

Others:

  • Department of Health

  • Healthcare Improvement Scotland

  • NHS England

  • Welsh Government

  • University of Birmingham

  • National Institute for Health and Care Excellence (NICE)